Abstract. A novel membrane protein from rat brain synaptic vesicles with an apparent 29,000 Mr (p29) was characterized. Using monospecific polyclonal antibodies, the distribution of p29 was studied in a variety of tissues by light and electron microscopy and immunoblot analysis. Within the nervous system, p29 was present in virtually all nerve terminals. It was selectively associated with small synaptic vesicles and a perinuclear region corresponding to the area of the Golgi complex. P29 was not detected in any other subcellular organelles including large dense-core vesicles. The distribution of p29 in various subcellular fractions from rat brain was very similar to that of synaptophysin and synaptobrevin. The highest enrichment occurred in purified small synaptic vesicles. Outside the nervous system, p29 was found only in endocrine cell types specialized for peptide hormone secretion. In these cells, p29 had a distribution very similar to that of synaptophysin. It was associated with microvesicles of heterogeneous size and shape that are primarily concentrated in the centrosomal-Golgi complex area. Secretory granules were mostly unlabeled, but their membrane occasionally contained small labeled evaginations. Immunoisolation of subcellular organelles from undifferentiated PC12 ceils with antisynaptophysin antibodies led to a concomitant enrichment of p29, synaptobrevin, and synaptophysin, further supporting a colocalization of all three proteins.
microvesicles of heterogeneous size and shape that are primarily concentrated in the centrosomal-Golgi complex area. Secretory granules were mostly unlabeled, but their membrane occasionally contained small labeled evaginations. Immunoisolation of subcellular organelles from undifferentiated PC12 ceils with antisynaptophysin antibodies led to a concomitant enrichment of p29, synaptobrevin, and synaptophysin, further supporting a colocalization of all three proteins.
P29 has an isoelectric point of ,',,5.0 and is not N-glycosylated. It is an integral membrane protein and all antibody binding sites are exposed on the cytoplasmic side of the vesicles. Two monoclonal antibodies raised against p29 cross reacted with synaptophysin, indicating the presence of related epitopes. P29, like synaptophysin, was phosphorylated on tyrosine residues by endogenous tyrosine kinase activity in intact vesicles.
C
HEMICAL signaling between neurons is mediated by regulated exocytosis of secretory vesicles that contain quanta of neurotransmitters. At least two types of secretory vesicles coexist in neurons: small synaptic vesicles (SSVs),~ which contain only nonpeptide neurotransmitters, and large dense-core vesicles (LDCVs), which contain neuroactive peptides, other polypeptides, and some nonpeptide transmitters. The molecular mechanisms involved in the biogenesis of these organelles and in their life cycles, including exocytosis, are still largely unknown (for review see Reichardt and Kelly, 1983; Kelly, 1988; De Camilli and Jahn, 1990) . To understand these processes in more detail, it is essential to obtain detailed information about the properties of the protein components present in their membranes.
Recently, several proteins have been identified in mammalian brain that are associated with virtually all SSVs independent of their neurotransmitter content (De Camilli and Jahn, 1990) . These include the synapsins-a family of homologous proteins associated with the cytoplasmic surface of the vesicles )-and several integral membrane proteins-synaptophysin (Jahn et al., 1985; Wiedenmann and Franke, 1985) , synaptobrevin (Baumert et al., 1989; Siidhof et al., 1989a ; [the two isoforms are also referred to as VAMP 1 and VAMP 2] Trimble et al., 1988; Elferink et al., 1989) , p65 (Matthew et al., 1981) , and SV2 (Buckley and Kelly, 1985) . Some of these proteins have been thoroughly characterized, and the primary structure of the synapsins (Sfidhof et al., 1989b) , synaptophysin (Leube et al., 1987; Sfidhof et al., 1987; Buckley et al., 1987) , and synaptobrevin (Sfidhof et al., 1989a; Trimble et al., 1988; Elferink et al., 1989) has been elucidated.
In neurons, the synapsins, synaptophysin, and synaptobrevin are selectively concentrated on SSVs (Navone et al., 1984 (Navone et al., , 1986 Banmert et al., 1989) . Outside the nervous system, the synapsins are largely absent, whereas synaptophysin, synaptobrevin, p65, and SV2 are present in certain endocrine tissues. In these tissues, the subeellular localization of synaptophysin was studied in detail 0Viedenmann and Franke, 1985; Navone et al., 1986 Jahn, 1990) .
In the present study, we report the characterization of a new membrane protein of 29,000 Mr present in SSVs. The protein is immunologically related to synaptophysin, undergoes endogenous tyrosine phospborylation in SSV fractions, and is expressed by both neurons and endocrine cells.
Materials and Methods

Materials
Nitrocellulose membrane filters (pore size 0.2 /tm) were obtained from Schieicher & Schuell, Inc. (Dassel, FRG) . 125I-labeled donkey anti-rabbit Ig (3.7 MBq/ml) and [T;2P]ATP (37 Mlkl/ml ) was purchased from Amersham Buchier GmbH (Braunschweig, FRG). Affinity-purified goat anti-mouse IgG, coupled to horseradish peroxidase, was from Bio-Rad Laboratories (Munich, FRG). Rhodamine-conjngated goat anti-rabbit IgGs were from Organon Teknika (Malvern, PA); colloidal gold-conjngnted goat anti-rabbit IgGs (GAR 5) was from Janssen Pharmaceutica (Olen, Belgium); and monoclonal anti-phosphotyrosine antibody was from Boehringer Mannheim GmbH (Mannheim, FRG). Protein A-colloidal gold complexes were prepared as described in Slot and Geuze (1983) . Ampholines (pH 3.5-10 and pH 5-7) were from Pbarmacia Fine Chemicals (Freiburg, FRG); recrystallized sodium cholate was from Calbiochem-Behring Corp. (Frankfurt, FRG); and pepride N-glycosidase F (N-Glycanase) was from Genzyme (Boston, MA). Eupergit CIZ beads (1 /~m diameter) were purchased from R6hm Pbarma (Darmstadt, FRG). PCI2 cells (C 251) were kindly provided by Drs. G. D. Borasio and H. Thoenen (Max-Planck-insritute for Psychiatry, Marriusried, FRG). All other reagents were ofanalyrical grade and obtained from standard commercial sources.
Immunochemical Techniques
Monoclonal and polyclonal antibodies were genera .t.~t. essentially as described earlier, using p29 as an antigen which was l~rified by preparative elactrophoresis (Baumert et al., 1989) . The polyclonal rabbit serum was affinity-purified using p29 excised from preparative immunoblots as immunondsorbent (Olmstedt, 1987) . Monoclonal and polyclonal antibodies against synaptophysin and synaptohi~vin were prepared as described (Jahn et al., 1985; Baumert et al., 1989) .
For the preparation of immunobeads, antibodies were immobilized on nonporous methacrylate microbends using a recently developed procedure (Burger et al., 1989) . For coupling of IgM-antibodies (CI 13.1), the protocol was slightly modified. IgM was enriched from ascites by fracrionated ammonium sulfate precipitation (30-50%) and extensively dialyzed against 150 mM NaCI. 500 mg of Eupergit CIZ methacrylate micmbeads were washed once with water and incubated with 10 mg IgM (final concentration 1 mg/mi) for 45 rain at 20°C. Inactivation of remaining binding sites and washing was performed as described (Burger et al., 1989) .
For immunoprecipitarion of p29, synaptic vesicle protein (final concentrarion 0.4 mg/ml) was solubilized in 150 mM NaCI, 10 mM sodium phosphate, pH 7.2, containing 1% (wt/voi) sodium cholate. The extract was incubated for 30 min on ice and spun for 20 min at 50,000 rpm in a Beckman Instruments, Inc. (Fullerton, CA) TLA 100.2 rotor. The supernatant was removed, and 20/zl C1 13.1 immunobends were added followed by end-overend rotation for 90 min at 4°C. Thereafter, the beads were sedimented by centrifugarion at 12,000 g for 30 s, washed three times with solubilization buffer, and finally resusponded in electrophoresis sample buffer.
SubceUular Fractionation
Synaptic vesicles were prepared essentially as described earlier (Nagy et al., 1976; Huttnor et aL, 1983; Jahn et al., 1985) . Briefly, cerebral cortices of 20 rats were homogenized in 150 ml of sucrose buffer (0.32 M sucrose, 0.1 mM PMSF, 2/~g/ml pepstarin A). The homogenate (H) was spun for 10 min at 800 g, yielding a pellet (Pj). The superuatant was centrifuged for 15 min at 9,200 g. The resulting pellet was washed once with sucrose buffer, yielding a crude synaptosomal pellet (P2). The supernntant was centrifuged at 165,000 g for 1 h, yielding pellet P3 and supernatant $3. P2 was resuspended in 12 ml of sucrose buffer and lysed by addition of 9 vul of distilled water, followed by homogenization. Hepes/NaOH buffer was added to a final concentration of 10 mM at pH 7.4. After 30 min of incubation, the fraction was spun at 25,000 g for 20 min (pellet LP,), and the supernarant was further centrifuged for 2 h at 165,000 g, yielding a crude synaptic vesicle pellet (LP2) and a supernntant (LS2). Vesicles were further purified by centrifugarion of LP2 on a continuous sucrose density gradient, yielding fraction SGV. This was chromatographed on controlled pore glass beads, resulting in purified synapric vesicles (fraction CPG). For preparative purposes, the preparation method described by Hell et al. (1988) was used.
Synaptophysin-containing microvesicles were isolated from PC12 cells using a modification of the recently described immunoisolation procedure for synaptic vesicles (Burger et al., 1989) . Cells were grown under standard conditions (Greene and Tischler, 1976) . After harvesting, cells were collected by centrifngntinn (,~3 x 107 cells) and homogenized in 0.5 ml of 0.32 M sucrose, 3 mM imidazule, pH 7.4, 0.1 mM PMSF, 2 ~g/ml pepsterin A by repetitively passing through a 27-gange needle. The homogenate was adjusted to 1 ml and centrifuged for 10 min at 10,000 g. To I ml of supernarant, 50 mg of C 7.2 immunobends were added as a 100-~d solution in 10 mM Tris-Cl, pH 7.4, 150 mM NaCI, and incubation was allowed to proceed for 1 h at 4°C under slow rotation. Beads were collected by centrifngation for 10 rain at 320 g and washed three rimes in 0.32 M sucrose, 10 mM Tris-CI, pH 7.4, 0.1 mM PMSF, 2 ttg/ml pepstarin A. The final pellet was incubated for 15 rain in 100 ~tl of the washing solution containing 2% SDS. The beads were removed by centrifugation, and an aliquot of the supernatant was used for SDS-PAGE and immunoblotting.
Immunocytochemistry
For light microscopy immunocytochemistry, tissue fixation, prepamrion of 10-~tm-thick frozen tissue sections, and immunefluorescence staining were performed as described (De Camilli et al., 1983a; Navone et al., 1986) . Immunogold labeling of agarose-embedded homogenates of bovine tissues (hypothalamus, anterior pituitary, and adrenal medulla) and of rat brains, was performed as described (De Camilli et al., 1983b; Navone et al., 1986) . A lyric fixation method was used for the brain tissues (to open resealed nerve endings) and an isoosmotic fixation method for the endocrine tissues (for a discussion of lytic and nonlytic fixation see De Camilli et al., 1983b) . Unless indicated otherwise, afffinity-purified rabbit antibody directed against p29 was used.
Other Analytical Techniques
SDS-PAGE was performed according to Laemmli (1970) . Immunobiotting was carried out according to Towbin et al. (1979) , using either mdioindinated (dilution 1:200) or horseradish pemxidase-coupled secondary antibodies as detection systems (Jahn et al., 1985) . Phase partition in Triton X-II4 was carried out according to Bordier (1981) . Phosphorylarion of vesicle proteins was performed essentially as described by Hirano et al. (1988) . Protein was determined either by the method of Bradford (1976) or by a modified Lowry procedure (Peterson, 1977) .
Results
Preparation and Characterization of Antibodies Directed against p29
Electrophoretic analysis of membrane proteins extracted from a highly purified SSV fraction revealed the presence of a protein band with an apparent 29,000 Mr (not showo; see Baumert et al., 1989 ). This protein band, referred to as p29, was purified by preparative electrophoresis and used for immunization of a rabbit and mice. Rabbit polyclonal antibodies were affinity purified from serum by blot adsorption. The antibodies reacted with a single band of an apparent 29000 Mr in an immunoblot of vesicle proteins (Fig. 1 a) . In addition, two monoclonal antibodies (clones C1 7.1 and C1 13.1, both IgM) were generated from two independent fusions. Both antibodies reacted specifically with two protein bands of 29,000 and 38,000 Mr ( Fig. 1, b and c). The identity of the 29,000-Mr protein, recognized by the polyclonal and monoclonal antibodies, respectively, was confirmed by immunoprecipitation from a detergent extract of rat brain homogenate. In further immunoprecipitation experiments, it was shown that the 38000-Mr protein band is identical to synaptophysin (data not shown). To examine the degree of cross-reactivity with synaptophysin, various dilutions of the monoclonal antibodies e l 7.1 and C1 13.1 were tested by immunoblotting (Fig. 1 b) . At higher dilutions (e.g., 10,000-fold), both antibodies displayed a preference for p29, showing a stronger reaction with p29 than with synaptophysin. These results indicate that both proteins share similar, although not identical, epitopes.
Cellular and SubceUular Localization of p29 within the Nervous System
To analyze the precise localization of p29 within the nervous system, the affinity-purified rabbit antibodies were used in immunocytochemical experiments. Immunofluorescence performed on frozen sections from various regions of the rat central nervous system revealed a punctate pattern of immunoreactivity (Fig. 2, a and b) . This pattern of immunoreactivity was very similar to that produced by antibodies directed against other SSV proteins (De Camilli et al., 1983a; Jahn et al., 1985; Navone et al., 1986; Baumert et al., 1989) . This is shown in Fig. 2 , b and c, by double labeling of the same brain stem section for p29 and synaptophysin. It was previously shown that the puncta correspond to individual nerve terminals. P29 immunofluorescence was also detectable on a network of thread-like structures that is present in neuronal perikarya and extends into the dendrites (Fig. 2 a) . This labeling pattern is characteristic of the Golgi complex of neurons . A widespread distribution of p29 was also found in the peripheral nervous system. lmmunoreactive nerve terminals were found in the skeletal muscle (Fig. 2, dandf) and, in the muscle layers of the stomach wall, the vas deferens, and the Auerbach plexus (not shown). P29 was also concentrated in sensory nerve endings (Fig. 2 f ) and in terminals of the posterior pituitary (not shown), which corresponds with the staining pattern obtained for other small synaptic vesicle proteins (De Camilli et al., 1988; Navone et al., 1989) .
The subcellular localization of p29 in the nervous tissue was analyzed by various complementary methods. Fig. 3 shows agarose-embedded cell fragments of rat and bovine brain homogenates that were immunogold labeled for p29. Gold label was only found in nerve terminals and was almost exclusively localized on SSVs. A few larger vesicular structures were labeled, which probably corresponds to intermediate stages in the life cycle of SSVs (Fig. 3 c) . Similar structures were also labeled using antibodies directed against synaptophysin (Navone et al., 1986) and synaptobrevin (Baumert et al., 1989) . Other membranous elements in nerve ter- minals, which probably represent tubules and cisternae of the endoplasmic reticulum, were not labeled. Also, no significant labeling of LDCVs or of the presynaptic plasrnalemma was observed (Fig. 3, b, d, e, arrowheads) . Virtually all nerve terminals with a disrupted plasma membrane (i.e., with SSVs accessible to antibodies; see De Camilli et al., 1983b) were labeled.
These results were supported by subcellular fractionation experiments. Immunoblot analysis of various fractions obtained during the isolation of SSVs from rat cerebral cortex showed that p29 has a distribution very similar to that of the SSV proteins synaptophysin and synaptobrevin, with the highest enrichment in the purified vesicle fraction (Fig. 4) .
Distribution of p29 outside the Nervous System
Outside the nervous system, significant levels of p29 immunoreactivity were observed only in various endocrine tissues specialized for regulated exocytotic secretion of proreins. Immunofluorescence of frozen tissue sections revealed p29 immunoreactivity in the anterior pituitary (Fig. 5 a) , in the adrenal medulla (Fig. 5 b) , in the intermediate pituitary, in the endocrine pancreas, in the parathyroids, and in sparse endocrine cells of the gut (not shown). P29 immunoreactivity was also found in cell lines derived from endocrine tissues (e.g., PC12 cells and insulinoma cells [Rin cells]) . In all these cells, immunoreactivity was present throughout the cytoplasm but was concentrated primarily in a paranuclear region corresponding to the location of the Golgi complex (Fig. 5, arrows) . Similar fluorescence patterns were obtained after double labeling the same cells for p29 and for synaptophysin (not shown), although the Golgi-like staining pattern was more intense for p29 than for synaptophysin.
Tissues which were both nonneuronal and nonendocrine did not contain any detectable amounts of p29. This was confirmed by immunoblotting (Fig. 6) . 
SubceUular Localization of p29 in Endocrine Cells
We have previously shown that synaptophysin in endocrine cells is localized on a microvesicle population (synaptic-like microvesicles) distinct from secretory granules (Navone et al., 1986) . Since the distribution of p29 in nonneuronal cells described in the previous section is similar to that of synaptophysin (Navone et al., 1986) , it was of interest to determine whether p29 has a similar subcellular localization. Fig. 7 shows a series of electron micrographs illustrating the localization of p29 by immunogold in subcellular parti- Figure 4 . Automdingraphy of an immunoblot of various subcellular fractions obtained during the isolation of rat brain synaptic vesicles labeled with afffinity-purified serum antibodies for synaptophysin (dilution 1:2~00; top) p29 (dilution 1:300; middle), and synaptobrevin (dilution 1:300; bottom). 5 ttg of each fraction was separated by SDS-PAGE on a 13 % gel and blotted onto nitrocellulose membrane filters. The blot was cut between the position of synaptophysin, p29, and synaptobrevin, respectively, and each part was stained with the respective antibody followed by incubation with t~I-labeled secondary antibody and autoradiography. To increase sensitivity, the exposure time for synaptobrevin was twice as long as that for p29 and synaptophysin. (Lanes 1-10 cles of bovine anterior pituitary (Fig. 7, a and b ) and adrenal medulla (Fig. 7, c-e) . P29 immunoreactivity was found primarily on microvesicles (Fig. 7, a-c) , while no significant labeling was observed on secretory granules. Occasionally, immunogold labeling was observed on relatively small dense-core structures and on small membrane evaginations of larger granules (Fig. 7 d) . Other labeled elements included large irregularly shaped vesicles with a clear core and tubular extensions of vacuolar structures (possibly endosomes; Fig. 7 e) . The strong labeling of the entire grannie membrane by antibodies directed against the chromaltin granule membrane protein cytochrome b561 (Fig. 7 f ) showed that the absence of labeling for p29 on the granule membrane is not due to inhibition of antibody access to binding sites.
These results show that the vesicle population containing p29 has a morphological appearance similar to the population containing synaptophysin (Navone et al., 1986) . This suggests that both proteins are coloealized on the same endomembrane system. To test this hypothesis, synaptophysincontaining vesicles were purified by "mamunoisolation from undifferentiated PC12 cells and analyzed for the presence of p29. For this purpose, monoclonal antibodies directed against synaptophysin were immobilized on the surface of nonporous methacrylate microbeads that were then used for organelle immunoadsorption. This method allows the onestep purification of synaptophysin-containing organelles from crude cell extracts. AS shown in Fig. 8, p29 coenriched with synaptophysin in the immunoadsorbed fraction. Similar enrichment was also found for synaptobrevin. The majority of each protein was removed from the starting fraction by this procedure (not shown), suggesting that all three proteins are colocalized in the same vesicle pool of PC12 cells. However, the relative abundance of the proteins in PCl2 cells is different from that in the brain. When compared with synaptophysin, both p29 and synaptobrevin are significantly less abundant in endocrine cells (data not shown).
Molecular Properties of p29
The isoelectric point of p29 was determined by isoelectric focusing followed by SDS-PAGE and immunoblotting of SSV proteins. It was found to be in the range of 5.0 (not shown), which is more acidic than that of synaptobrevin but similar to that of synaptophysin.
To analyze the nature of the association of p29 with the vesicle membrane, phase partition of synaptic vesicle proteins was performed using the detergent Triton X-114 (Bordier, 1981) . As shown in Fig. 9 a, p29 was selectively enriched in the detergent phase (lane D), suggesting that it contains hydrophobic, detergent-binding domains. This is indicative of the presence of transmembrane segments. Since antibodies to p29 bind to the outer surface of SSVs (see electron micrographs above), a portion of the molecule is probably exposed on the cytoplasmic side. Furthermore, we investigated whether p29 is modified by N-glycosylation. A detergent extract of SSVs was treated with peptide N-glycosidase F to remove N-linked sugar moieties. As shown in Fig.  9 b, the electrophoretic mobility of p29 remained unchanged whereas synaptopbysin (which is known to be N-glycosylated; Navone et ai., 1986; Rehm et al., 1986) was partially shifted to an apparent 34,000 M, (compare control sample [lane C] with endoglycosidase-treated sample [lane El). Similar results were obtained after treating PC12 cells with tunicamycin to inhibit core glycosylation (not shown). Together, these results indicate that p29 is not N-glycosylated in neurons and PC12 cells.
In a final series of experiments, we investigated whether p29, like synaptophysin, undergoes endogenous tyrosine phosphorylation. This possibility was suggested by recent studies reporting the endogenous tyrosine phosphorylation of synaptophysin and of additional proteins in the molecular mass range of 26-30 kD in synaptic vesicle fractions (Pang et al., 1988; Hirano et al., 1988) . To examine whether the 30-kD band described in these studies is identical with p29, a vesicle-enriched fraction was incubated with [-/32p]ATP under conditions optimal for tyrosine phosphorylation. As shown in Fig. 10 a, a number of protein bands were labeled, indicating phosphorylation by endogenous protein kinases. Three of the hands (corresponding to 38,000, 29,000, and 24,000 Mr) contain phosphotyrosine (Pang et al., 1988; Hirano et al., 1988 ; our unpublished observations). Three Figure 6t Immunoblot of various rat tissue homogenates (10 ~tg/lane), labeled for p29 with afffinity-purified serum antibodies, using radiolabeling with an ~25I-linked secondary antibody for detection as described in the legend to Fig. 4 . For comparison, the upper part of the blot was cut off and labeled for synaptophysin using the same protocol. To increase sensitivity, the strip labeled for p29 was exposed six times longer than that for synaptophysin. (Lanes 1-7) Cortex, cerebellum, spinal cord, skeletal muscle, liver, kidney, and lung, respectively. identical bands were recognized by a phosphotyrosinespecific monoclonal antibody (Fig. 10 b, lane tyr-P) . To demonstrate that the 29,000-Mr band is identical with p29, the vesicle fraction was extracted with cholate at the end of the phosphorylation reaction and subjected to high-speed centrifugation. P29 was immunoprecipitated from the resulting supernatant using monoclonal antibody C1 13.1 conjugated to methacrylate beads, which recognizes p29 as well as synaptophysin. As shown in Fig. 10 c, both p29 and synaptophysin were selectively immunopreeipitated (lane 13.1) and shown to contain phosphotyrosine (lane tyr-P). We conclude that p29 is a substrate for endogenous tyrosine kinase.
D i s c u s s i o n
In the present study, we have characterized p29, a new membrane protein of SSVs. P29 is a nonglycosylated, integral membrane protein with 29,000 Mr and an acidic isoelectric point. Portions of the molecule are exposed at the cytoplasmic surface of the vesicle as indicated by antibody binding (see Fig. 6 ) and protease digestion experiments (our unpublished observations).
P29 appears to have some structural similarity with synaptophysin. Both monoclonal antibodies raised against denatured p29 cross react with synaptophysin in immunoblotting and immunoprecipitation assays. The high degree of specificity in both assay systems suggests that this cross-reactivity is not due to a nonspecific side reaction, which is known to occur with antibodies of the IgM subclass. However, it can be clearly excluded that p29 is a breakdown product of synaptopbysin. The polyclonal antibody used in our study is monospecific for p29, and both monoclonal antibodies display a preference for p29 (see Fig. 1 ). Furthermore, none of the available anti-synaptophysin antibodies, including those specific for internal epitopes (Jahn et al., 1985; Johnston et al., 1989a) , react with p29 (our unpublished observations).
A few reports have been published concerning proteins of brain coated and synaptic vesicles with molecular weights similar to that of p29. Analysis of membrane proteins present in brain coated vesicles revealed the presence of a 29000-Mr protein that was probably derived from synaptic vesicles (Pfeffer and Kelly, 1985; . Furthermore, a membrane protein of 30,000 Mr has been described in guinea pig brain synaptic vesicles (Obata et al., 1987) . Since synaptic vesicles contain several membrane proteins of similar molecular weight (our unpublished observations), further work is required to determine whether any of these proteins are related to p29.
Within the nervous system, p29 is present in virtually all nerve terminals where it is selectively associated with the membranes of SSVs. Thus, p29 appears to be a new member of a group of proteins, including the synapsins, synaptophysin, and synaptobrevin, that are present in all SSVs irrespective of the specific neurotransmitter content (for review see De Camilli and Jahn, 1990) . The SSV proteins SV2 (BuckIcy and and p65 (Matthew et al., 1981) apparently share this widespread distribution, although the idea that synaptophysin and p65 are colocalized has been disputed (Volknandt et al., 1988) . The absence of p29 from the membranes of LDCVs confirms our previous observations that the membrane compositions of SSVs and LDCVs are dissimilar (Navone et al., 1984 (Navone et al., , 1986 Baumert et al., 1989) . This indicates that SSVs do not originate from recycling LDCV membranes as suggested by other investigators (Lowe et al., 1988; Kelly, 1988; Boarder, 1989) unless extensive protein sorting within the nerve terminal is involved. Rather, the data add further experimental support to our view that SSVs and LDCVs have an independent biogenesis and independent life cycles (Navone et al., 1986; De Camilli and Jahn, 1990) .
Outside the nervous system, p29 was detected only in cells specialized for endocrine secretion by regulated exocytosis (neuroendocrine cells). Again, its subcellular localization is very similar to that of synaptophysin (Navone et al., 1986) and synaptobrevin(cf. Fig. 10 ; Baumert et al., 1989) , indicating a colocalization of all three proteins. This was confirmed by their parallel enrichment upon immunoisolation of subeellular membranes. Structures labeled for p29 were mostly microvesicles with clear content. The membranes of secretory granules were unlabeled, with the except.ion of occasional labeling of focal evaginations. This may indicate that segregation of p29 from secretory granule proteins is completed during granule maturation after leaving the Golgi complex. Protein segregation by focal evagination of membrane patches has been shown to be involved in the secretory pathway of liver cells where the asialoglycoprotein receptor is separated from secretory proteins by such a mechanism (Geuze et al., 1987) .
Together, these results are consistent with our previous suggestion that the presence of SSV proteins in endocrine cells reflects the presence of a population of microvesicles (synaptic-like microvesicles) distinct from secretory granules (Navone et al., 1986; De Camilli and Jahn, 1990) . It should be noted, however, that the absence of SSV membrane proteins from secretory granules has recently been dispuled. Based on immunoisolation or subeellular fractionation experiments, it was reported that synaptophysin, p65, and SV2 are common to SSVs and to endocrine secretory granules (Lowe et al., 1988; Obendorf et al., 1988) . At present, it is difficult to explain this discrepancy. It is possible that synaptopbysin, and also the other SSV proteins, are present in the membranes of mature secretory granules at a concentration below the detection limit of our immunocytochemical techniques. However, the secretory granule fractions may be contaminated with synaptic-like microvesicles that remain attached to secretory granules after isolation (e.g., Fig. 7 ). The latter interpretation is supported by our recent observation that synaptophysin-containing microvesicles can be separated from chromaffin granules by immunoadsorption, leaving behind a granule fraction containing high amounts of cytochrome b56~ but no synaptophysin (our unpublished observations).
The function of synaptic-like microvesicles in endocrine cells remains to be established. Recent studies on synaptophysin-containing microvesicles in PC12 cells and in fibroblasts transfected with the cDNA of synaptophysin have provided important insights into the relationship of these membranes with other vesicle-routing pathways. It appears that synaptic-like microvesicles are organelles that recycle between the region of the Golgi complex and the plasmamembrane (Johnston et al., 1989b) . When synaptophysin is expressed in Chinese hamster ovary cells, which naturally do not express the protein, it is targeted to a microvesicle population similar to that involved in the recycling of transferrin receptors. These findings raise the possibility that synapticlike microvesicles in endocrine cells may be related to vesicles that recycle plasmalemma receptors. SSV exocytosis and recycling in synaptic terminals could then be the neuronal adaptation of a general membrane recycling pathway.
The function of p29 remains unknown. However, an important clue is provided by our finding that p29 can undergo endogenous tyrosine phosphorylation in SSV fractions, adding another element of similarity to synaptophysin, which is the major substrate for tyrosine kinase activity in synaptic vesicles (Pang et al., 1988) . It is likely that the protooncogene pp60 ~'~ is responsible for this phosphorylation since pp60 ~= is present in synaptic vesicles (Hirano et al., 1988) . The concentration of pp61Y -'~ and of some of the major substrates for tyrosine phosphorylation in SSVs is intriguing. It was suggested that pp60 ~'~ expression in the nervous system is correlated not only with cell proliferation but also with the development or maturation of neuronal processes and synaptic contacts (Cotton and Brugge, 1983; Sorge et al., 1984) . Tyrosine phosphorylation of p29 and synaptophysin may, therefore, be involved in a major regulatory mechanism during the life cycle of SSVs and/or in controlling the assembly of SSV clusters at presynaptic sites.
